• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

N-Methyl-3-(2-methyl-1H-imidazol-1-yl)-propan-1-amine dihydrochloride: A Comprehensive Overview

The compound with CAS No. 1059626-18-4, commonly referred to as N-Methyl-3-(2-methyl-1H-imidazol-1-yl)-propan-1-amine dihydrochloride, is a significant molecule in the field of organic chemistry and pharmaceutical research. This compound is characterized by its unique structure, which includes a methyl group, a imidazole ring, and an amine functional group. The presence of these functional groups makes it versatile for various applications in drug discovery, material science, and synthetic chemistry.

Recent studies have highlighted the potential of N-Methyl-3-(2-methyl-1H-imidazol-1-yl)-propan-1-amine dihydrochloride in the development of novel therapeutic agents. Its ability to act as a bioisostere in drug design has been particularly noteworthy. Bioisosteres are structural analogs that can replace parts of a molecule without significantly altering its pharmacological properties, thereby enhancing drug efficacy and reducing side effects. This property has made it a valuable tool in the optimization of lead compounds for various therapeutic targets.

In addition to its role in drug discovery, this compound has also been explored for its potential in catalytic applications. The imidazole ring, a key structural component, exhibits excellent coordination abilities, making it suitable for use as a ligand in transition metal catalysts. Recent research has demonstrated its effectiveness in facilitating asymmetric catalysis, a process crucial for the synthesis of chiral molecules with high enantioselectivity. This has opened new avenues for its application in the synthesis of complex organic molecules, including those with intricate stereochemical requirements.

The synthesis of N-Methyl-3-(2-methyl-1H-imidazol-1-yl)-propan-1-amine dihydrochloride involves a multi-step process that typically begins with the preparation of the imidazole ring. This is followed by alkylation and subsequent protonation to form the dihydrochloride salt. The reaction conditions, including temperature and solvent choice, play a critical role in ensuring high yields and purity of the final product. Recent advancements in catalytic methods have further streamlined this synthesis process, making it more efficient and scalable for industrial applications.

From a structural perspective, the molecule's amide-like interactions and hydrogen bonding capabilities contribute to its stability and reactivity. These properties are particularly advantageous in the design of peptide mimetics and bioactive agents. Moreover, its ability to form stable complexes with metal ions has been leveraged in the development of coordination polymers and metallo-drugs.

Looking ahead, the continued exploration of N-Methyl-3-(2-methyl-1H-imidazol-1-yll-propan-l-amine dihydrochloride is expected to yield further insights into its potential applications. Its role as a building block in medicinal chemistry is likely to expand as researchers uncover new ways to harness its unique chemical properties. Additionally, ongoing studies into its pharmacokinetics and toxicity profiles will be instrumental in determining its suitability for clinical use.

In conclusion, N-Methyl3-(2-methyI-lH-imidazol-l-yll-propan-l-amine dihydrochloride stands out as a promising compound with diverse applications across multiple disciplines. Its structural versatility, coupled with recent advancements in synthetic methodologies and catalytic applications, positions it as a key player in future research endeavors.

• 2258-21-1(3-(2-Methyl-1H-imidazol-1-yl)propan-1-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)